All of what I have said is based on fact that no doctor would dispute. So, if you bring these arguments to any doctor, they should agree. It's based on steroid hormone physiology, how different drugs we take work. Just show this to doctors, they will understand.

As to levels being measured to ensure that risk is kept to a minimum, this is based on the assumption that the higher the level, the higher the risk. If that were so, then four things contradict this assumption.
First, pregnancy. Pregnant women typically reach levels of 40,000 pg/ml (x 3.671 in pmol/L), up to 75,000 during the third trimester. They do not appear to be dying left and right. The worldwide population is still growing, often in places where hygiene is less than optimal (third world countries). Our species is clearly not on the decline.
http://cebp.aacrjournals.org/cgi/content-nw/full/12/5/452/T1Second, in men who have prostate cancer, who are at an advanced age, high estrogen doses are prescribed, in many times more than what is typically prescribed for us. Yet, studies have found no complications and indeed, an increased protection from thrombosis.
J Urol. 2005 Aug;174(2):527-33; discussion 532-3.
Transdermal estradiol therapy for prostate cancer reduces
thrombophilic activation and protects against thromboembolism.
"These results suggest that transdermal estradiol reduces thrombophilic activation in men with advanced prostate cancer, and protects against the risk of thrombosis."
Third, from this study is stated
Am J Obstet Gynecol. 1993 Dec;169(6):1549-53.
Fibrinolytic parameters in women undergoing ovulation induction.
"Down-regulation of the fibrinolytic system was observed as estradiol levels increased. However, thrombin formation did not change, thus suggesting that elevated circulating estradiol alone does not predispose to a thromboembolic event."
Lastly, despite very high doses of estrogen prescribed in the past to transsexual women and prostate cancer patients, from the 1960's to the 1990's, very few breast cancer incidences have been noted either by urologists, Harry Benjamin himself and Gooren's team in Holland, international recognized. Also, no liver complications were noted by Harry Benjamin.